Default company panoramic image
Logo

Safeguard Biosystems Holdings Ltd

Molecular diagnostics focused on high volume detection of many DNA targets at one time from one sample for pathogen/species identification.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Northwood, England, GB
  • Currency GBP
  • Founded May 2006
  • Employees 5
  • Website sgbio.com

Company Summary

Molecular diagnostic company focused on rapid detection of large numbers (multiplexed) of DNA & proteins from one sample in health, food (meat/fish) & industrial/commercial applications cost effectively. Target: Large scale screening/speciation applications with £5m plus market opportunities which current practices cannot meet. 1st app – Bacterial DNA detection. Customers will include dairy cooperatives/processors and farming operations.

Team

  • Default avatar
    George Aaron
    Mr

    Chairman and CEO. Throughout his career, George Aaron has been in healthcare related industries, starting as head of international acquisitions for Schering Plough. He founded or acquired four start-ups, in both drug development and diagnostics, which have all had successful exits. All companies were based on the model of outsourced R&D, as is the case with Safeguard Biosystems.

  • Default avatar
    Richard Strafehl
    Mr

    Co-founder, Director. Is an experienced Canadian entrepreneur with broad-based skills in information technology, business development and executive management including taking a company public. Richard Strafehl has progressed through major corporations including Xerox, NCR Canada and AT&T. He also has a history of developing high-tech start-ups, four of which have become public.

  • Default avatar
    Howard Mark Sherman
    Mr

    CFO, Director. With 17 years experience in corporate and International banking in the City of London primarily with Charterhouse Bank, Howard Sherman has acted as a financial consultant to businesses in a variety of sectors, including start-ups. He was a key player in the establishment of Safeguard Biosystems as a U.K. company and previous funding rounds.

Advisors

  • Default avatar
    Burlingtons Solicitors
    Lawyer
    Unconfirmed
    Default avatar
    UHY Hacker Young
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    NewSmith Capital 30%
    Unconfirmed
    Default avatar
    Isabel Fox 9%
    Unconfirmed
    Default avatar
    AM2 Bermuda (3C) 4%
    Unconfirmed